Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Conformis, Inc. stock logo
CFMS
Conformis
$2.26
$2.25
$1.05
$7.25
$17.80M1.3999,585 shs7,000 shs
D8 Holdings Corp. stock logo
DEH
D8
$0.30
-3.3%
$11.31
$9.50
$11.66
$12.74MN/A380,936 shs207,069 shs
Eargo, Inc. stock logo
EAR
Eargo
$70.50
$52.85
$1.47
$8.48
$1.46B1.523,347 shsN/A
Inogen, Inc. stock logo
INGN
Inogen
$8.69
+5.5%
$7.15
$4.13
$11.98
$204.62M1.1531,525 shs657,426 shs
Sientra, Inc. stock logo
SIEN
Sientra
$0.43
$0.16
$4.94
$2.08M2.044.15 million shs3.44 million shs
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Conformis, Inc. stock logo
CFMS
Conformis
0.00%0.00%0.00%0.00%+89.92%
D8 Holdings Corp. stock logo
DEH
D8
-2.25%-1.96%-13.09%-27.93%-84.53%
Eargo, Inc. stock logo
EAR
Eargo
0.00%0.00%0.00%+2,580.61%+1,181.82%
Inogen, Inc. stock logo
INGN
Inogen
+5.46%+23.61%+12.56%+5.85%-21.71%
Sientra, Inc. stock logo
SIEN
Sientra
0.00%0.00%0.00%-71.00%-88.24%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Conformis, Inc. stock logo
CFMS
Conformis
N/AN/AN/AN/AN/AN/AN/AN/A
D8 Holdings Corp. stock logo
DEH
D8
N/AN/AN/AN/AN/AN/AN/AN/A
Eargo, Inc. stock logo
EAR
Eargo
N/AN/AN/AN/AN/AN/AN/AN/A
Inogen, Inc. stock logo
INGN
Inogen
2.1713 of 5 stars
1.02.00.03.91.91.71.3
Sientra, Inc. stock logo
SIEN
Sientra
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Conformis, Inc. stock logo
CFMS
Conformis
N/AN/AN/AN/A
D8 Holdings Corp. stock logo
DEH
D8
N/AN/AN/AN/A
Eargo, Inc. stock logo
EAR
Eargo
N/AN/AN/AN/A
Inogen, Inc. stock logo
INGN
Inogen
2.00
Hold$7.00-19.45% Downside
Sientra, Inc. stock logo
SIEN
Sientra
2.00
HoldN/AN/A

Current Analyst Ratings

Latest EAR, INGN, DEH, SIEN, and CFMS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/8/2024
Inogen, Inc. stock logo
INGN
Inogen
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$6.00 ➝ $7.00
5/8/2024
Inogen, Inc. stock logo
INGN
Inogen
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold
4/9/2024
Inogen, Inc. stock logo
INGN
Inogen
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold
2/15/2024
Inogen, Inc. stock logo
INGN
Inogen
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform
(Data available from 5/10/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Conformis, Inc. stock logo
CFMS
Conformis
$57.06M0.31N/AN/A$4.07 per share0.56
D8 Holdings Corp. stock logo
DEH
D8
N/AN/AN/AN/A$0.12 per shareN/A
Eargo, Inc. stock logo
EAR
Eargo
$41.11M35.61N/AN/A$4.87 per share14.48
Inogen, Inc. stock logo
INGN
Inogen
$315.66M0.65N/AN/A$8.79 per share0.99
Sientra, Inc. stock logo
SIEN
Sientra
$90.55M0.00N/AN/A($0.04) per share0.00

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Conformis, Inc. stock logo
CFMS
Conformis
-$50.47M-$5.61N/AN/AN/A-72.72%-86.46%-47.65%N/A
D8 Holdings Corp. stock logo
DEH
D8
-$9.46MN/A0.00N/AN/AN/AN/AN/A
Eargo, Inc. stock logo
EAR
Eargo
-$157.49M-$7.52N/AN/A-263.14%-135.08%-96.37%N/A
Inogen, Inc. stock logo
INGN
Inogen
-$102.45M-$4.41N/AN/AN/A-32.46%-38.98%-27.03%8/5/2024 (Estimated)
Sientra, Inc. stock logo
SIEN
Sientra
-$73.31M-$5.57N/AN/AN/A-65.93%N/A-40.45%N/A

Latest EAR, INGN, DEH, SIEN, and CFMS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2024Q1 2024
Inogen, Inc. stock logo
INGN
Inogen
-$0.76-$0.62+$0.14-$0.62$73.67 million$78.03 million    
2/27/2024Q4 2023
Inogen, Inc. stock logo
INGN
Inogen
-$0.65-$1.14-$0.49-$1.14$78.09 million$75.90 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Conformis, Inc. stock logo
CFMS
Conformis
N/AN/AN/AN/AN/A
D8 Holdings Corp. stock logo
DEH
D8
N/AN/AN/AN/AN/A
Eargo, Inc. stock logo
EAR
Eargo
N/AN/AN/AN/AN/A
Inogen, Inc. stock logo
INGN
Inogen
N/AN/AN/AN/AN/A
Sientra, Inc. stock logo
SIEN
Sientra
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Conformis, Inc. stock logo
CFMS
Conformis
0.64
5.07
3.30
D8 Holdings Corp. stock logo
DEH
D8
N/A
0.13
0.13
Eargo, Inc. stock logo
EAR
Eargo
N/A
3.22
2.97
Inogen, Inc. stock logo
INGN
Inogen
N/A
2.86
2.55
Sientra, Inc. stock logo
SIEN
Sientra
N/A
0.57
0.31

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Conformis, Inc. stock logo
CFMS
Conformis
10.31%
D8 Holdings Corp. stock logo
DEH
D8
65.44%
Eargo, Inc. stock logo
EAR
Eargo
80.53%
Inogen, Inc. stock logo
INGN
Inogen
89.94%
Sientra, Inc. stock logo
SIEN
Sientra
15.38%

Insider Ownership

CompanyInsider Ownership
Conformis, Inc. stock logo
CFMS
Conformis
3.80%
D8 Holdings Corp. stock logo
DEH
D8
N/A
Eargo, Inc. stock logo
EAR
Eargo
0.81%
Inogen, Inc. stock logo
INGN
Inogen
0.99%
Sientra, Inc. stock logo
SIEN
Sientra
1.53%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Conformis, Inc. stock logo
CFMS
Conformis
2957.88 million7.58 millionNot Optionable
D8 Holdings Corp. stock logo
DEH
D8
343.13 millionN/ANot Optionable
Eargo, Inc. stock logo
EAR
Eargo
24320.76 million20.59 millionNot Optionable
Inogen, Inc. stock logo
INGN
Inogen
83423.55 million23.31 millionOptionable
Sientra, Inc. stock logo
SIEN
Sientra
30411.96 million11.78 millionOptionable

EAR, INGN, DEH, SIEN, and CFMS Headlines

SourceHeadline
Pace Industries in Grafton announces it will lay off 90 workers beginning in JunePace Industries in Grafton announces it will lay off 90 workers beginning in June
msn.com - May 9 at 11:34 PM
Global Breast Reconstruction Surgery and Treatment Market Will Surge at a CAGR of 5.9% to Reach USD 1.61 Billion By 2033Global Breast Reconstruction Surgery and Treatment Market Will Surge at a CAGR of 5.9% to Reach USD 1.61 Billion By 2033
fmiblog.com - May 8 at 3:31 AM
Nine Wisconsin companies, including CNH Industrial, announced layoffs in April. About 890 workers affected.Nine Wisconsin companies, including CNH Industrial, announced layoffs in April. About 890 workers affected.
msn.com - April 30 at 1:23 PM
Buyer of California manufacturer Sientra will move company’s HQ to FranklinBuyer of California manufacturer Sientra will move company’s HQ to Franklin
biztimes.com - April 29 at 5:21 PM
Sientra to lay off 245, sell assets to Tiger AestheticsSientra to lay off 245, sell assets to Tiger Aesthetics
rubbernews.com - April 29 at 5:21 PM
Breast Implants Market Will Grow Nearly USD 5.2 Billion At A Rate Of 7.7% By 2033Breast Implants Market Will Grow Nearly USD 5.2 Billion At A Rate Of 7.7% By 2033
pharmiweb.com - April 26 at 3:41 PM
Tiger Aesthetics Medical, LLC Acquires Assets of Sientra, Inc.Tiger Aesthetics Medical, LLC Acquires Assets of Sientra, Inc.
bignewsnetwork.com - April 24 at 6:29 PM
California-based manufacturer of breast implants closing Franklin facility as part of bankruptcyCalifornia-based manufacturer of breast implants closing Franklin facility as part of bankruptcy
biztimes.com - April 22 at 2:14 PM
Sientra Inc SIENQSientra Inc SIENQ
morningstar.com - April 22 at 12:31 AM
Nuance Medical Completes Acquisition of BIOCORNEUM Scar Treatment Brand, to Become a Part of the Biodermis PortfolioNuance Medical Completes Acquisition of BIOCORNEUM Scar Treatment Brand, to Become a Part of the Biodermis Portfolio
finance.yahoo.com - April 18 at 3:40 PM
Aesthetic Implants Market: In-Depth Analysis, Emerging Trends, Growth Drivers, and Forecasts up to 2033Aesthetic Implants Market: In-Depth Analysis, Emerging Trends, Growth Drivers, and Forecasts up to 2033
pharmiweb.com - April 13 at 7:57 AM
Breast Implants Market to Reach USD 7.8 Billion by 2032, CAGR 6.7% | Marketresearch.bizBreast Implants Market to Reach USD 7.8 Billion by 2032, CAGR 6.7% | Marketresearch.biz
pharmiweb.com - April 12 at 5:47 AM
Nasdaq (NDAQ) Initiated with a Buy at BarclaysNasdaq (NDAQ) Initiated with a Buy at Barclays
markets.businessinsider.com - April 11 at 7:34 AM
Medical Aesthetics Market Future Projections: USD 51.7 Billion By 2032 With A Consistent 14.7% Growth RateMedical Aesthetics Market Future Projections: USD 51.7 Billion By 2032 With A Consistent 14.7% Growth Rate
pharmiweb.com - April 8 at 4:33 PM
Global Extremity Tissue Expanders Industry Expected to Grow at a Startling 6.3% CAGR to Reach US$ 1,842.6 Million by 2028 | FMI AnalysisGlobal Extremity Tissue Expanders Industry Expected to Grow at a Startling 6.3% CAGR to Reach US$ 1,842.6 Million by 2028 | FMI Analysis
fmiblog.com - April 4 at 6:23 PM
Aesthetic Implants Market on Track for Remarkable Expansion, Forecasted to Surpass USD 10 Billion by 2032 | Market.usAesthetic Implants Market on Track for Remarkable Expansion, Forecasted to Surpass USD 10 Billion by 2032 | Market.us
pharmiweb.com - April 4 at 8:22 AM
Sientra Sells Business Parts for $50M+Sientra Sells Business Parts for $50M+
ocbj.com - April 3 at 3:53 PM
Sientra, Inc.: Sientra Announces Completion and Winning Bidders of its Section 363 Sales AuctionSientra, Inc.: Sientra Announces Completion and Winning Bidders of its Section 363 Sales Auction
finanznachrichten.de - April 3 at 10:53 AM
Nuance Medical Agrees to Acquire BIOCORNEUM Scar Treatment BrandNuance Medical Agrees to Acquire BIOCORNEUM Scar Treatment Brand
finance.yahoo.com - April 3 at 10:53 AM
Sientra Announces Completion and Winning Bidders of its Section 363 Sales AuctionSientra Announces Completion and Winning Bidders of its Section 363 Sales Auction
globenewswire.com - April 2 at 6:30 PM
Global Gynecomastia Procedures Market Size To Exceed USD 1900 Million by 2033 | CAGR Of 8.05%Global Gynecomastia Procedures Market Size To Exceed USD 1900 Million by 2033 | CAGR Of 8.05%
finance.yahoo.com - March 15 at 4:23 AM
Global Cosmetic Implants Market, with a special focus on dental implants, is anticipated to hit a remarkable US$ 17.9 Billion by 2032Global Cosmetic Implants Market, with a special focus on dental implants, is anticipated to hit a remarkable US$ 17.9 Billion by 2032
fmiblog.com - March 14 at 11:23 PM
Firm Retention Summary: SientraFirm Retention Summary: Sientra
wsj.com - March 7 at 3:39 PM
Sientra Declares Bankruptcy, Seeks BuyerSientra Declares Bankruptcy, Seeks Buyer
ocbj.com - February 26 at 7:00 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Conformis logo

Conformis

NASDAQ:CFMS
Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. The company offers personalized knee replacement products, including iUni, iDuo, iTotal CR, and iTotal PS, as well as provides iTotal Identity and Identity Imprint knee replacement products. It also offers Conformis Hip System and Cordera hip replacement, which are hip replacement products; and iJigs, a personalized single-use patient-specific instrumentation. The company markets and sells its products to orthopedic surgeons, hospitals, and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Spain, Portugal, the Netherlands, Belgium, the Dutch Antilles, Suriname, Australia, Brazil, the United Arab Emirates, the Sultanate of Oman, Italy, Poland, and other markets. Conformis, Inc. was incorporated in 2004 and is headquartered in Billerica, Massachusetts.
D8 logo

D8

NYSE:DEH
D8 Holdings Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Central, Hong Kong.
Eargo logo

Eargo

NASDAQ:EAR
Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. It markets and sells hearing aids. The company sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014. Eargo, Inc. was incorporated in 2010 and is headquartered in San Jose, California.
Inogen logo

Inogen

NASDAQ:INGN
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
Sientra logo

Sientra

NASDAQ:SIEN
Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. The company also provides fat transfer systems; body contouring products; facial and nasal implants; saline filled sizers. It serves to hospitals, surgery centers, plastic surgeons, dermatologists, and other specialties. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Irvine, California. On February 12, 2024, Sientra, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.